XML 46 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
RESTATEMENT
3 Months Ended
Mar. 31, 2014
Common stock shares due and payable upon receipt of a salvage and recovery contract  
RESTATEMENT

NOTE 14 - RESTATEMENT

 

In connection with the review of convertible debt as of March 31, 2014, the Company identified an accounting interpretation issue in the accounting for two (2) convertible notes issued by two separate unrelated third party entities. The notes were issued on January 16, 2014 and March 17, 2014.

 

The effects of the restatement on reported amounts for the three months ended March 31, 2014 are presented below in the following tables:

 

    31-Mar-14  
    As Reported     Adjustments     As Restated  
                   
Total assets   $ 171,884     $ -     $ 171,884  
                         
Accounts payable and accrued expense   $ 150,126     $ -     $ 150,126  
Convertible notes payable, net of discounts     140,906       (30,195 )     110,711  
Convertible notes payable, related parties, net of discounts     21,958       11       21,969  
Convertible notes payable, in default     251,300       -       251,300  
Convertible notes payable, in default - related parties     153,500       -       153,500  
Derivative liability     22,291       (22,291 )        
Convertible notes payable, at fair value     -       172,940       172,940  
Notes payable, in default     30,000       -       30,000  
Notes payable, in default - related parties     7,500       -       7,500  
Total liabilities     777,581       120,465       898,046  
                         
Preferred stock, $0.0001 par value - 50,000,000 shares authorized;                        
Series A preferred stock, $0.0001 par value - 7 shares authorized; 7 shares issued                        
and outstanding at March 31, 2014 and December 31, 2013     -       -       -  
Series B preferred stock, $0.0001 par value - 60 shares authorized; 60 shares issued                        
and outstanding at March 31, 2014 and December 31, 2013     -       -       -  
Common stock, $0.0001 par value - 950,000,000 shares authorized; 874,532,999 and                        
844,216,349 shares issued and outstanding at March 31, 2014     87,230       -       87,230  
Additional paid-in capital     7,795,611       (50,000 )     7,745,611  
Accumulated deficit     (8,488,538 )     (70,465 )     (8,559,003 )
Total stockholders' deficit     (605,697 )     (120,465 )     (726,162 )
Total liabilities and stockholders' deficit   $ 171,884     $ -     $ 171,884  
                         
                         
    Three months ended March 31, 2014  
    As reported     Adjustments     As restated  
Revenue   $ -     $ -     $ -  
                         
Total operating expenses     312,804       -       312,804  
                         
Loss from operations     (312,804 )     -       (312,804 )
                         
Other income (expense):                        
Interest expense     (161,762 )     (61,177 )     (222,939 )
Gain (loss) on change in fair value of derivatives     9,288       (9,288 )     -  
Net loss   $ (465,278 )   $ (70,465 )   $ (535,743 )